Efficacy of TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis

BackgroundTransarterial chemoembolization (TACE) is currently widely used in the treatment of patients with unresectable hepatocellular carcinoma. However, the combination of TACE with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) during treatment remains controversial. T...

Повний опис

Бібліографічні деталі

Автори:	Kailin Ye, Jiale Zhou, Jie Lin, Yongzhi Li, Yansong Luo, Fei Xie
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2025-12-01
Серія:	Frontiers in Oncology
Предмети:	hepatocellular carcinoma TACE tyrosine kinase inhibitors immune checkpoint inhibitors meta-analysis
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1707622/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!